SEP 06, 2019 9:35 AM PDT

Cannabis Holds Promise in Aiding PTSD

WRITTEN BY: C Reardon

Cannabinoids, the active components of the cannabis plant, may have the potential to treat PTSD by reducing nightmares and aiding poor sleep habits. However further research is needed in order to determine whether these drugs should be a regular part of clinical practice.

Dr. Chandni Hindocha (UCL Clinical Psychopharmacology Unit), lead author of recent study published in the Journal of Dual Diagnosis, explains that “there has been a recent surge of interest in the use of cannabinoids to treat PTSD, particularly from military veterans, many of whom are already self-medicating or obtaining prescriptions in some American states."

Photo Source: Pixabay.com

PTSD most typically consists of re-experiencing a traumatic event through nightmares, flashbacks and intrusive memories. It often includes hyper-reactivity and insomnia.

Trauma-focused cognitive-behavioral therapy is the most popular psychotherapy currently used to combat PTSD. Although trauma-focused cognitive-behavioral therapy has been shown to be effective, not everyone can access this kind of talking therapy, so many people suffering from PTSD still need prescribed medications. The existing drugs approved for PTSD are not always effective and may actually have adverse effects. Due to this fact, the medical field is quickly trying to identify new treatments.

The number of people who have turned to cannabinoids to treat PTSD is quickly growing, as it is an approved treatment for this disorder in most states in the USA permitting medical cannabis. Cannabinoids, which are made up of tetrahydrocannabinol (THC) and cannabidiol (CBD), can change how the brain processes a person’s memories. These cannabinoids will act as a in-built endocannabinoid system for the brain, a system that also regulates other brain functions affected by PTSD.

The research team for this study conducted a systematic review assessing the quality of any previous study where an individual suffering from a PTSD diagnosis uses a cannabinoid to reduce their symptoms, whether it be smoked cannabis, THC, CBD or a synthetic cannabinoid called nabilone. Researchers found only 10 studies that met their requirements and criteria, each of the 10 proving to have a high risk of bias due to sample size, lack of a control group or placebo, short follow up times, inconsistencies in reporting, and retrospective study design.

Researchers say that there are still many unanswered questions in regard to safety and efficacy of cannabis-based medications for PTSD.

"Based on the evidence, we cannot yet make any clinical recommendations about using cannabinoids to treat PTSD. Current prescribing of cannabinoids for PTSD is not backed up by high quality evidence, but the findings certainly highlight the need for more research, particularly long-term clinical trials," said the study's senior author, Dr Michael Bloomfield (UCL Psychiatry and the Traumatic Stress Clinic, St Pancras Hospital).

About the Author
  • Chelsey is a content strategist and copywriter with a business degree. She has a background in public relations and marketing and enjoys writing about various topics, from health, to lifestyle, to women’s issues. Since 2016, she has written for a variety of online publications, earning well over 100,000 shares. She published her first book in 2019.
You May Also Like
OCT 05, 2021
Microbiology
Insects & Spiders Seem to Carry & Spread Antibiotic Resistance
OCT 05, 2021
Insects & Spiders Seem to Carry & Spread Antibiotic Resistance
Antibiotic resistance is seen as a growing threat to public health, and scientists have been trying to develop new antib ...
OCT 07, 2021
Health & Medicine
A School-based Approach to Combatting Adolescent Obesity
OCT 07, 2021
A School-based Approach to Combatting Adolescent Obesity
It should come as no surprise that obesity is a significant public health concern associated with astronomical economic ...
OCT 08, 2021
Cannabis Sciences
Research on Cannabis Patches and Topical Lotions to Manage Symptoms of Parkinson's Disease
OCT 08, 2021
Research on Cannabis Patches and Topical Lotions to Manage Symptoms of Parkinson's Disease
As medical cannabis becomes legalized around the globe, patients need to explore which routes of cannabis delivery best ...
OCT 14, 2021
Drug Discovery & Development
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
OCT 14, 2021
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
The conjunctiva is a thin membrane that covers the front of the eyes and the inner eyelids. The conjunctiva produces tea ...
OCT 15, 2021
Genetics & Genomics
Genes Seem to Significantly Impact the Results We Get From Exercise
OCT 15, 2021
Genes Seem to Significantly Impact the Results We Get From Exercise
Individual health is shaped by many different factors, including the sequences and expression levels of genes, the makeu ...
OCT 17, 2021
Technology
How Do People Feel About Facial Recognition Tools In Healthcare?
OCT 17, 2021
How Do People Feel About Facial Recognition Tools In Healthcare?
Facial image data and recognition tools have become a nearly ubiquitous part of our society: we use it to unlock smartph ...
Loading Comments...